We are live on
!
Find out more
MCM
Marathon Capital Management Portfolio holdings
AUM
$445M
1-Year Est. Return
26.09%
This Fund
S&P 500
This Quarter
Est. Return
-16.38%
1 Year Est. Return
+26.09%
3 Year Est. Return
+49.93%
5 Year Est. Return
+48.4%
10 Year Est. Return
+349.58%
AUM
$310M
AUM Growth
-$38.8M
(-11%)
Cap. Flow
+$27.3M
Cap. Flow
% of AUM
8.81%
Top 10 Holdings %
Top 10 Hldgs %
50.74%
Holding
149
New
56
Increased
34
Reduced
41
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price
TROW
|
+$4.94M |
| 2 |
Lennar Class B
LEN.B
|
+$3.16M |
| 3 |
Amazon
AMZN
|
+$1.63M |
| 4 |
Honeywell
HON
|
+$1.43M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Financial
FNF
|
+$5.94M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.3M |
| 3 |
TETRA Technologies
TTI
|
+$1.29M |
| 4 |
Corteva
CTVA
|
+$1.12M |
| 5 |
TPC
Tutor Perini Cor
TPC
|
+$902K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 43.07% |
| 2 | Technology | 16.65% |
| 3 | Healthcare | 11.36% |
| 4 | Industrials | 10.53% |
| 5 | Consumer Discretionary | 4.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
T. Rowe Price
TROW
$25B
| $104M | 33.49% |
912,560
+38,885
| +4% | +$4.94M |
|
2
Enphase Energy
ENPH
$5.26B
| $9.38M | 3.03% |
48,064
-295
| -0.6% | -$53.3K |
|
3
MetLife
MET
$60B
| $6.6M | 2.13% |
105,184
+225
| +0.2% | +$14.9K |
|
4
IBM
IBM
$198B
| $6.31M | 2.04% |
44,709
-1,904
| -4% | -$257K |
|
|
5
TETRA Technologies
TTI
$1.36B
| $5.76M | 1.86% |
1,419,000
-293,685
| -17% | -$1.29M |
|
|
6
Bristol-Myers Squibb
BMY
$124B
| $5.72M | 1.85% |
74,253
-17,110
| -19% | -$1.3M |
|
7
Apple
AAPL
$4.8T
| $5.49M | 1.77% |
40,160
-129
| -0.3% | -$19.5K |
|
8
Corning
GLW
$135B
| $4.8M | 1.55% |
152,364
+1,646
| +1% | +$56.7K |
|
9
Johnson & Johnson
JNJ
$604B
| $4.69M | 1.51% |
26,399
-73
| -0.3% | -$13K |
|
10
Allison Transmission
ALSN
$9.35B
| $4.65M | 1.5% |
121,004
+764
| +0.6% | +$29.2K |
|
11
First Horizon
FHN
$12.1B
| $4.56M | 1.47% |
208,500
+475
| +0.2% | +$10.7K |
|
12
AbbVie
ABBV
$449B
| $4.53M | 1.46% |
29,596
+121
| +0.4% | +$18.5K |
|
13
GSK
GSK
$102B
| $4.45M | 1.44% |
81,793
-1,988
| -2% | -$110K |
|
14
Qualcomm
QCOM
$182B
| $4.45M | 1.44% |
34,839
+551
| +2% | +$74.8K |
|
15
Identive
INVE
$66.5M
| $4.4M | 1.42% |
380,055
+15,575
| +4% | +$195K |
|
16
Microsoft
MSFT
$2.93T
| $4.34M | 1.4% |
16,900
+112
| +0.7% | +$30.4K |
|
17
Merck
MRK
$312B
| $4.25M | 1.37% |
46,634
+40
| +0.1% | +$3.55K |
|
|
AVID
18
DELISTED
Avid Technology Inc
AVID
| $3.85M | 1.25% |
148,535
-8,700
| -6% | -$254K |
|
19
Berkshire Hathaway Class B
BRK.B
$1.06T
| $3.36M | 1.08% |
12,299
-112
| -0.9% | -$35.1K |
|
20
Chevron
CVX
$376B
| $3.32M | 1.07% |
22,962
-439
| -2% | -$72.6K |
|
|
B
21
Barrick Mining
B
$58.3B
| $3.29M | 1.06% |
185,925
+900
| +0.5% | +$19.5K |
|
|
ABB
22
DELISTED
ABB Ltd
ABB
| $3.1M | 1% |
116,049
+219
| +0.2% | +$6.51K |
|
23
Copa Holdings
CPA
$5.7B
| $3.08M | 0.99% |
48,525
-300
| -0.6% | -$21.1K |
|
|
AAWW
24
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $3.01M | 0.97% |
48,732
-780
| -2% | -$53.3K |
|
25
Xerox
XRX
$343M
| $2.99M | 0.97% |
201,260
+14,275
| +8% | +$253K |
|
Similar funds
RWM
WC
NAMP
BI
MLIC
JDLA
GC
SCA
Marathon Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Marathon Capital Management held 149 positions worth $310M, down 11% from $348M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Marathon Capital Management deployed $27.3M of net new capital in Q2 2022, opening 56 new positions and adding to 34 existing holdings. Its largest new stake was Lennar Class B: 52,032 shares worth $2.9M.
By sector, the portfolio is most concentrated in Financials at 43% of assets, down from 48% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $1.3M trimmed.
- Marathon Capital Management's largest Q2 2022 buy was Lennar Class B: 52,032 shares worth $2.9M.
- Marathon Capital Management added most to T. Rowe Price in Q2 2022, an estimated $4.94M increase.
- Marathon Capital Management's biggest Q2 2022 reduction was Bristol-Myers Squibb, cutting an estimated $1.3M.
- Marathon Capital Management fully exited Fidelity National Financial in Q2 2022, selling an estimated $5.94M.
- Marathon Capital Management's ten largest holdings make up 51% of its $310M portfolio in Q2 2022.
- Marathon Capital Management opened 56 new positions and closed 3 in Q2 2022.
- Marathon Capital Management's portfolio value fell 11% quarter-over-quarter to $310M.
Based on Marathon Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.